We and others have previously reported that a polymorphism in the CNDP1 gene, encoding serum carnosinase-1 (CN1), is associated with lower risk of developing diabetic nephropathy in patients with type 2 diabetes [6,7,8,9,10]. This evidence concerns the gene CNDP1 and type 2 diabetes mellitus.